OYAN INTERNATIONAL CO., LIMITED – Trademark Portfolio
Entity Type: 22
OYAN INTERNATIONAL CO., LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include JZNDK, MPOSVG, and ANDITOR. The owner is based in HONG KONG.
UNIT 11, 9/F THE CLOUD NO.111 TUNG CHAU ST TAI KOK TSUI
HONG KONG 999077 , CN
Showing of trademarks Trademarks
Trademark Classifications
OYAN INTERNATIONAL CO., LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does OYAN INTERNATIONAL CO., LIMITED have?
OYAN INTERNATIONAL CO., LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does OYAN INTERNATIONAL CO., LIMITED file in?
OYAN INTERNATIONAL CO., LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are OYAN INTERNATIONAL CO., LIMITED's most well-known trademarks?
OYAN INTERNATIONAL CO., LIMITED's registered trademark portfolio includes well-known marks such as JZNDK, MPOSVG, and ANDITOR. These are among 3 currently registered trademarks in the portfolio.
What is OYAN INTERNATIONAL CO., LIMITED's trademark registration success rate?
OYAN INTERNATIONAL CO., LIMITED has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.